Vollenweider, P

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants

Zhou, B., Lu, Y., Hajifathalian, K., Bentham, J., Di Cesare, M., Danaei, G., Bixby, H., Cowan, M., Ali, M., Taddei, C., et al. (2016) · The Lancet

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 4,311

Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study

Heinzer, R., Vat, S., Marques-Vidal, P., Marti-Soler, H., Andries, D., Tobback, N., Mooser, V, Preisig, M., Malhotra, A., Waeber, G., et al. (2015) · The Lancet Respiratory Medicine

Obstructive Sleep Apnea ResearchSleep and related disorders

Cited by 2,481

A new highly penetrant form of obesity due to deletions on chromosome 16p11.2

Walters, R. G., Jacquemont, S., Valsesia, A., de Smith, A. J., Martinet, D., Andersson, J., Falchi, M., Chen, F., Andrieux, J., Lobbens, S., et al. (2010) · Nature

Genomic variations and chromosomal abnormalitiesGenetic Associations and Epidemiology

Cited by 543

Body fat and sympathetic nerve activity in healthy subjects.

Scherrer, U., Randin, D., Tappy, L., Vollenweider, P., Jéquier, E., & Nicod, P. (1994) · Circulation

Cardiovascular and exercise physiologyDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 383

Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans

Vollenweider, P., Tappy, L., Randin, D., Schneiter, P., Jéquier, E., Nicod, P., & Scherrer, U. (1993) · Journal of Clinical Investigation

Cardiovascular and exercise physiologyDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 321

Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans.

Vollenweider, P., Randin, D., Tappy, L., Jéquier, E., Nicod, P., & Scherrer, U. (1994) · Journal of Clinical Investigation

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular and exercise physiology

Cited by 285

Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans.

Scherrer, U., Vollenweider, P., Randin, D., Jéquier, E., Nicod, P., & Tappy, L. (1993) · Circulation

Cardiovascular and exercise physiologyDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 131

The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression

Samaan, Z., Anand, S., Zhang, X., Desai, D., Rivera, M., Pare, G., Thabane, L., Xie, C., Gerstein, H., Engert, J. C., et al. (2013) · Molecular Psychiatry

Genetic Associations and EpidemiologyNeurotransmitter Receptor Influence on Behavior

Cited by 129